ICER issues affordability and access alert for tardive dyskinesia drugs

By Alicia Parker | Jan 5, 2018 | 8:41 PM GMT

The Institute for Clinical and Economic Review issued an affordability and access alert for tardive dyskinesia drugs Ingrezza valbenazine (MT-5199, NBI-98854) and Austedo